Recent NCNA News
- NuCana Regains Compliance with Nasdaq Minimum Bid Price Requirement • GlobeNewswire Inc. • 05/01/2024 08:01:00 PM
- NuCana Announces Completion of ADS Ratio Change • GlobeNewswire Inc. • 04/16/2024 12:00:00 PM
- NuCana Presents Data at the AACR 2024 Annual Meeting Highlighting the Ability of NUC-7738 to Profoundly Alter Tumor Biology in a Paired Biopsy Clinical Study • GlobeNewswire Inc. • 04/09/2024 08:30:00 PM
- NuCana Announces Plan to Implement ADS Ratio Change • GlobeNewswire Inc. • 03/27/2024 08:30:00 PM
- NuCana Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 03/20/2024 08:01:00 PM
- NuCana to Present at TD Cowen’s 44th Annual Health Care Conference • GlobeNewswire Inc. • 02/27/2024 01:00:00 PM
- NuCana to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference • GlobeNewswire Inc. • 02/06/2024 01:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/16/2023 09:08:52 PM
- NuCana Reports Third Quarter 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 11/16/2023 09:01:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/13/2023 09:22:50 PM
- NuCana Announces Listing Transfer to Nasdaq Capital Market • GlobeNewswire Inc. • 11/10/2023 09:01:00 PM
- NuCana to Present at the Jefferies London Healthcare Conference • GlobeNewswire Inc. • 11/08/2023 09:01:00 PM
- NuCana to Participate in the Truist Securities 2023 BioPharma Symposium • GlobeNewswire Inc. • 11/01/2023 08:01:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/16/2023 11:10:58 AM
- NuCana Presents Promising Data on NUC-7738 at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023 • GlobeNewswire Inc. • 10/16/2023 11:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 10/13/2023 08:09:55 PM
- NuCana Presents Encouraging Data on NUC-3373 in Colorectal Cancer at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023 • GlobeNewswire Inc. • 10/13/2023 04:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/18/2023 12:10:56 PM
- NuCana Announces Presentations at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics 2023 • GlobeNewswire Inc. • 09/18/2023 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 08/16/2023 08:08:42 PM
- NuCana Reports Second Quarter 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/16/2023 08:01:00 PM
- NuCana to Present at the Jefferies Healthcare Conference • GlobeNewswire Inc. • 06/01/2023 12:00:00 PM
- NuCana Reports First Quarter 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/17/2023 08:01:00 PM
- NuCana Announces Receipt of Nasdaq Notice • GlobeNewswire Inc. • 05/12/2023 08:01:00 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM